Implications of Implementing the 2021 KDIGO Blood Pressure Guideline

Alexander G Logan

doi:10.1016/j.jacc.2022.02.038

Implications of Implementing the 2021 KDIGO Blood Pressure Guideline

J Am Coll Cardiol. 2022 May 3;79(17):1687-1689. doi: 10.1016/j.jacc.2022.02.038.

Author

Alexander G Logan¹

Affiliation

¹ Department of Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada; Division of Nephrology, University Health Network, Toronto, Ontario, Canada; Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: [email protected].

PMID: 35483756
DOI: 10.1016/j.jacc.2022.02.038

No abstract available

Keywords: antihypertensive medications; blood pressure; blood pressure measurements; blood pressure targets for treatment; chronic kidney disease; clinical practice guidelines; hypertension; masked hypertension; white-coat hypertension.

Publication types

Editorial
Comment

MeSH terms

Blood Pressure
Female
Humans
Male
Renal Insufficiency, Chronic*